Skip to Main Content

Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation. Our choice today is blueberry cobbler. Meanwhile, we have assembled a menu of tidbits to help you along. So please dig in. Have a smashing day, and please feel free to forward any secrets you come across. Our “in basket” is always open….

More than two dozen big buyers of prescription medicines expect prices will rise by an average of 8% annually over the next three years, a slight uptick from a year ago. And 19% believe a “substantial portion” of the anticipated increases can be attributed to a shift to newer, pricier therapies, which is up from 8% a year ago, STAT writes, citing a new survey. Notably, the slightly higher projection “may be the continuation of a trend toward expectations for double-digit increases” for prescription medicines in the future, wrote analysts at Cowen, who queried 26 hospitals, pharmacy benefit managers, and health maintenance organizations that purchased about $90 billion in medicines in 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment